Gut microbes on the risk of advanced adenomas

More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. To analyze the characteristic microbes in AA. Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina Hi...

Full description

Saved in:
Bibliographic Details
Published inBMC microbiology Vol. 24; no. 1; pp. 264 - 14
Main Authors Jing, Zhuang, Zheng, Wu, Jianwen, Song, Hong, Shen, Xiaojian, Yu, Qiang, Wei, Yunfeng, Yin, Xinyue, Wu, Shuwen, Han, Feimin, Zhao
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 18.07.2024
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. To analyze the characteristic microbes in AA. Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze α diversity and β diversity. α diversity included box diagram, and β diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed. The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively. Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing.
AbstractList Background More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. Objective To analyze the characteristic microbes in AA. Methods Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze [alpha] diversity and [beta] diversity. [alpha] diversity included box diagram, and [beta] diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed. Results The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively. Conclusion Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing. Keywords: Advanced adenomas, Gut bacteria, Enteroviruses, Metagenomic sequencing, Prediction model
More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. To analyze the characteristic microbes in AA. Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze [alpha] diversity and [beta] diversity. [alpha] diversity included box diagram, and [beta] diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed. The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively. Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing.
Abstract Background More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. Objective To analyze the characteristic microbes in AA. Methods Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze α diversity and β diversity. α diversity included box diagram, and β diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed. Results The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively. Conclusion Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing.
More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC.BACKGROUNDMore than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC.To analyze the characteristic microbes in AA.OBJECTIVETo analyze the characteristic microbes in AA.Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze α diversity and β diversity. α diversity included box diagram, and β diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed.METHODSFecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze α diversity and β diversity. α diversity included box diagram, and β diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed.The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively.RESULTSThe abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively.Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing.CONCLUSIONPrevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing.
The bacteria (including Prevotella sp900557255 , Alistipes putredinis , Megamonas funiformis , etc. ) and viruses (including Lilyvirus , Felixounavirus , and Drulisvirus , etc.) existed differences in AA. And there were correlations between AA and basic information, lipid index and serological index. Prediction models based on bacteria and viruses were established to distinguish AA, and the accuracy reached 87.27% and 83.33%. A new typing method was established based on bacteria and viruses to divide gut microbes into 4 subtypes. Prediction models after typing had higher accuracy (100% in B1V1, 96.34% in B1V2, 100% in B2V1, 98.46% in B2V2).
The bacteria (including Prevotella sp900557255, Alistipes putredinis, Megamonas funiformis, etc.) and viruses (including Lilyvirus, Felixounavirus, and Drulisvirus, etc.) existed differences in AA. And there were correlations between AA and basic information, lipid index and serological index.Prediction models based on bacteria and viruses were established to distinguish AA, and the accuracy reached 87.27% and 83.33%.A new typing method was established based on bacteria and viruses to divide gut microbes into 4 subtypes.Prediction models after typing had higher accuracy (100% in B1V1, 96.34% in B1V2, 100% in B2V1, 98.46% in B2V2).
More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. To analyze the characteristic microbes in AA. Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze α diversity and β diversity. α diversity included box diagram, and β diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed. The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively. Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing.
ArticleNumber 264
Audience Academic
Author Xinyue, Wu
Zheng, Wu
Jing, Zhuang
Feimin, Zhao
Hong, Shen
Shuwen, Han
Qiang, Wei
Xiaojian, Yu
Jianwen, Song
Yunfeng, Yin
Author_xml – sequence: 1
  givenname: Zhuang
  surname: Jing
  fullname: Jing, Zhuang
– sequence: 2
  givenname: Wu
  surname: Zheng
  fullname: Zheng, Wu
– sequence: 3
  givenname: Song
  surname: Jianwen
  fullname: Jianwen, Song
– sequence: 4
  givenname: Shen
  surname: Hong
  fullname: Hong, Shen
– sequence: 5
  givenname: Yu
  surname: Xiaojian
  fullname: Xiaojian, Yu
– sequence: 6
  givenname: Wei
  surname: Qiang
  fullname: Qiang, Wei
– sequence: 7
  givenname: Yin
  surname: Yunfeng
  fullname: Yunfeng, Yin
– sequence: 8
  givenname: Wu
  surname: Xinyue
  fullname: Xinyue, Wu
– sequence: 9
  givenname: Han
  surname: Shuwen
  fullname: Shuwen, Han
– sequence: 10
  givenname: Zhao
  surname: Feimin
  fullname: Feimin, Zhao
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39026166$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhS1URB_wB1igSGzKIsV2Ej9WqKqgjFQJicfachx76iGxi-1U0F_PTaeUToWQF7auv3OufH0O0V6IwSL0kuATQgR7mwkVjNWYtjVuWsLqmyfogLSc1JQIvPfgvI8Oc95gTLho-DO030hMGWHsANXnc6kmb1Lsba5iqMqlrZLP36voKj1c62DsAAcb4qTzc_TU6THbF3f7Efr24f3Xs4_1xafz1dnpRW06KUrNtezFYEzvrIBWHWat67jjTLiOYahLw11POyOcNQBoKS21ncPCEagPzRFabX2HqDfqKvlJp18qaq9uCzGtlU7Fm9EqJ1vO4C39IGzbD1w2uDVacyFF2zFCwOvd1utq7ic7GBtK0uOO6e5N8JdqHa8VIbRjjVwcju8cUvwx21zU5LOx46iDjXNWDRaUUc75gr5-hG7inALMCihJqKSyFX-ptYYX-OAiNDaLqToVmAjRNC0F6uQfFKzBwodBFJyH-o7gzY4AmGJ_lrWec1arL5932VcPp3I_jj_JAIBuAYhGzsm6e4RgtcRPbeOnIH7qNn7qBkTikcj4oouPy2T9-D_pb76P2xw
CitedBy_id crossref_primary_10_1186_s42523_025_00378_z
crossref_primary_10_1016_j_apsoil_2024_105663
crossref_primary_10_3390_biomedicines13010009
Cites_doi 10.1038/s41564-019-0551-1
10.1038/s41591-019-0458-7
10.3390/antibiotics10070806
10.1136/bmj.n877
10.1016/j.tim.2018.09.006
10.1186/s12866-022-02712-w
10.1038/s41591-018-0308-z
10.3390/microorganisms10030664
10.1016/j.gtc.2018.04.004
10.1172/JCI155101
10.1128/mBio.01143-21
10.1038/s41579-021-00559-y
10.3748/wjg.v28.i30.4053
10.1186/gb-2011-12-6-r60
10.1053/j.gastro.2023.03.208
10.1093/cid/cix881
10.1093/advances/nmaa104
10.3748/wjg.v24.i1.5
10.1128/spectrum.01593-22
10.3389/fimmu.2020.615056
10.1177/1756284819836620
10.4161/gmic.1.3.12360
10.1007/s12094-022-03061-w
10.1080/19490976.2021.1949096
10.3389/fimmu.2022.921546
10.1016/S2213-2600(19)30397-2
10.3390/v11070656
10.1002/cam4.3289
10.1016/S2468-1253(18)30282-6
10.1126/sciimmunol.abn6660
10.12968/jowc.2018.27.Sup4.S24
10.1038/nrmicro1656
10.1053/j.gastro.2018.08.063
10.1128/AEM.02627-17
10.3322/caac.21660
10.1038/s41598-020-73902-7
10.1016/j.ccell.2018.03.004
10.3389/fmicb.2018.02200
10.1038/s41588-022-01088-x
10.1038/ajg.2017.360
10.1186/gb-2014-15-3-r46
10.1016/j.semcancer.2021.10.004
10.3389/fcimb.2022.1054808
10.1183/13993003.02881-2020
ContentType Journal Article
Copyright 2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7QL
7T7
7U9
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12866-024-03416-z
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Database
Proquest Central Journals
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
Proquest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Proquest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic


Publicly Available Content Database
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1471-2180
EndPage 14
ExternalDocumentID oai_doaj_org_article_f9476616bd8e4bd79304caa789845611
PMC11256391
A801883342
39026166
10_1186_s12866_024_03416_z
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: PublicWelfare Technology Application Research Program of Huzhou
  grantid: No. 2023GY18
– fundername: Zhejiang Medical and Health Technology Project
  grantid: No.2023KY1178
– fundername: China University Industry University Research Innovation Fund
  grantid: No.2023HT078
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ISR
ITC
KQ8
LK5
LK8
M1P
M48
M7P
M7R
MM.
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~02
-A0
3V.
ACRMQ
ADINQ
AGJBV
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QL
7T7
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c598t-7a9b8dccbfe83905064f57f768f560ccb9c7fb25c8fec390a99e2e5f08f1fb2d3
IEDL.DBID M48
ISSN 1471-2180
IngestDate Wed Aug 27 01:23:35 EDT 2025
Thu Aug 21 18:33:04 EDT 2025
Fri Jul 11 09:38:15 EDT 2025
Fri Jul 25 10:52:38 EDT 2025
Tue Jun 17 22:09:57 EDT 2025
Tue Jun 10 21:07:33 EDT 2025
Fri Jun 27 05:37:33 EDT 2025
Wed Feb 19 02:07:42 EST 2025
Tue Jul 01 04:31:46 EDT 2025
Thu Apr 24 22:58:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Enteroviruses
Gut bacteria
Advanced adenomas
Prediction model
Metagenomic sequencing
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c598t-7a9b8dccbfe83905064f57f768f560ccb9c7fb25c8fec390a99e2e5f08f1fb2d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3091292948?pq-origsite=%requestingapplication%
PMID 39026166
PQID 3091292948
PQPubID 42585
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_f9476616bd8e4bd79304caa789845611
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11256391
proquest_miscellaneous_3082627771
proquest_journals_3091292948
gale_infotracmisc_A801883342
gale_infotracacademiconefile_A801883342
gale_incontextgauss_ISR_A801883342
pubmed_primary_39026166
crossref_primary_10_1186_s12866_024_03416_z
crossref_citationtrail_10_1186_s12866_024_03416_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-07-18
PublicationDateYYYYMMDD 2024-07-18
PublicationDate_xml – month: 07
  year: 2024
  text: 2024-07-18
  day: 18
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC microbiology
PublicationTitleAlternate BMC Microbiol
PublicationYear 2024
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References C Dubé (3416_CR4) 2017; 112
B Liu (3416_CR12) 2022; 13
A Adibi (3416_CR43) 2020; 8
N Segata (3416_CR26) 2011; 12
WR Becker (3416_CR30) 2022; 54
Z Qi (3416_CR44) 2022; 22
A Piantadosi (3416_CR23) 2021; 12
M Song (3416_CR6) 2021; 373
W Yinhang (3416_CR29) 2023; 25
OF Ahmad (3416_CR7) 2019; 4
AEV Quaglio (3416_CR13) 2022; 28
AF Peery (3416_CR3) 2019; 156
ZH Shen (3416_CR9) 2018; 24
A Tett (3416_CR33) 2021; 19
XJ Shen (3416_CR31) 2010; 1
B Yilmaz (3416_CR10) 2019; 25
3416_CR35
3416_CR14
3416_CR36
PJ Simner (3416_CR22) 2018; 66
MU Ijaz (3416_CR27) 2018; 9
I Mukhopadhya (3416_CR37) 2019; 12
3416_CR38
H Tilg (3416_CR8) 2018; 33
S Han (3416_CR24) 2022; 10
J Diep (3416_CR16) 2019; 4
H Sung (3416_CR1) 2021; 71
HH Zhao-Fleming (3416_CR34) 2018; 27
F Adiliaghdam (3416_CR20) 2022; 7
V Sintchenko (3416_CR39) 2007; 5
Y Zhao (3416_CR19) 2021; 12
P Zéboulon (3416_CR41) 2020; 10
S Yachida (3416_CR21) 2019; 25
PJ Pickhardt (3416_CR5) 2018; 47
Z Wang (3416_CR17) 2022; 86
DE Wood (3416_CR25) 2014; 15
3416_CR40
Y Cheng (3416_CR15) 2020; 11
3416_CR42
JM Bech (3416_CR2) 2023; 165
S Kilcher (3416_CR18) 2019; 27
E Caparrós (3416_CR11) 2021; 13
3416_CR28
X Zhong (3416_CR32) 2022; 12
References_xml – volume: 4
  start-page: 2523
  issue: 12
  year: 2019
  ident: 3416_CR16
  publication-title: Nat Microbiol
  doi: 10.1038/s41564-019-0551-1
– volume: 25
  start-page: 968
  issue: 6
  year: 2019
  ident: 3416_CR21
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0458-7
– ident: 3416_CR38
  doi: 10.3390/antibiotics10070806
– volume: 373
  start-page: n877
  year: 2021
  ident: 3416_CR6
  publication-title: BMJ
  doi: 10.1136/bmj.n877
– volume: 27
  start-page: 355
  issue: 4
  year: 2019
  ident: 3416_CR18
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2018.09.006
– volume: 22
  start-page: 312
  issue: 1
  year: 2022
  ident: 3416_CR44
  publication-title: BMC Microbiol
  doi: 10.1186/s12866-022-02712-w
– volume: 25
  start-page: 323
  issue: 2
  year: 2019
  ident: 3416_CR10
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0308-z
– ident: 3416_CR40
  doi: 10.3390/microorganisms10030664
– volume: 47
  start-page: 515
  issue: 3
  year: 2018
  ident: 3416_CR5
  publication-title: Gastroenterol Clin North Am
  doi: 10.1016/j.gtc.2018.04.004
– ident: 3416_CR14
  doi: 10.1172/JCI155101
– volume: 12
  start-page: e0114321
  issue: 4
  year: 2021
  ident: 3416_CR23
  publication-title: mBio
  doi: 10.1128/mBio.01143-21
– volume: 19
  start-page: 585
  issue: 9
  year: 2021
  ident: 3416_CR33
  publication-title: Nat Rev Microbiol
  doi: 10.1038/s41579-021-00559-y
– volume: 28
  start-page: 4053
  issue: 30
  year: 2022
  ident: 3416_CR13
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v28.i30.4053
– volume: 12
  start-page: R60
  issue: 6
  year: 2011
  ident: 3416_CR26
  publication-title: Genome Biol
  doi: 10.1186/gb-2011-12-6-r60
– volume: 165
  start-page: 121
  issue: 1
  year: 2023
  ident: 3416_CR2
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2023.03.208
– volume: 66
  start-page: 778
  issue: 5
  year: 2018
  ident: 3416_CR22
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cix881
– volume: 12
  start-page: 546
  issue: 2
  year: 2021
  ident: 3416_CR19
  publication-title: Adv Nutr
  doi: 10.1093/advances/nmaa104
– volume: 24
  start-page: 5
  issue: 1
  year: 2018
  ident: 3416_CR9
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v24.i1.5
– volume: 10
  start-page: e0159322
  issue: 6
  year: 2022
  ident: 3416_CR24
  publication-title: Microbiol Spectr
  doi: 10.1128/spectrum.01593-22
– volume: 11
  start-page: 615056
  year: 2020
  ident: 3416_CR15
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.615056
– volume: 12
  start-page: 175628481983662
  year: 2019
  ident: 3416_CR37
  publication-title: Th Adv Gastroenterol
  doi: 10.1177/1756284819836620
– volume: 1
  start-page: 138
  issue: 3
  year: 2010
  ident: 3416_CR31
  publication-title: Gut Microbes
  doi: 10.4161/gmic.1.3.12360
– volume: 25
  start-page: 1661
  issue: 6
  year: 2023
  ident: 3416_CR29
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-022-03061-w
– volume: 13
  start-page: 1949096
  issue: 1
  year: 2021
  ident: 3416_CR11
  publication-title: Gut Microbes
  doi: 10.1080/19490976.2021.1949096
– volume: 13
  start-page: 921546
  year: 2022
  ident: 3416_CR12
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2022.921546
– volume: 8
  start-page: 1013
  issue: 10
  year: 2020
  ident: 3416_CR43
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(19)30397-2
– ident: 3416_CR35
  doi: 10.3390/v11070656
– ident: 3416_CR28
  doi: 10.1002/cam4.3289
– volume: 4
  start-page: 71
  issue: 1
  year: 2019
  ident: 3416_CR7
  publication-title: Lancet Gastroenterol Hepatol
  doi: 10.1016/S2468-1253(18)30282-6
– volume: 7
  start-page: eabn6660
  issue: 70
  year: 2022
  ident: 3416_CR20
  publication-title: Sci Immunol
  doi: 10.1126/sciimmunol.abn6660
– volume: 27
  start-page: S24
  issue: Sup4
  year: 2018
  ident: 3416_CR34
  publication-title: J Wound Care
  doi: 10.12968/jowc.2018.27.Sup4.S24
– volume: 5
  start-page: 464
  issue: 6
  year: 2007
  ident: 3416_CR39
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro1656
– volume: 156
  start-page: 254
  issue: 1
  year: 2019
  ident: 3416_CR3
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2018.08.063
– ident: 3416_CR36
  doi: 10.1128/AEM.02627-17
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  ident: 3416_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 10
  start-page: 16973
  issue: 1
  year: 2020
  ident: 3416_CR41
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-73902-7
– volume: 33
  start-page: 954
  issue: 6
  year: 2018
  ident: 3416_CR8
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2018.03.004
– volume: 9
  start-page: 2200
  year: 2018
  ident: 3416_CR27
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2018.02200
– volume: 54
  start-page: 985
  issue: 7
  year: 2022
  ident: 3416_CR30
  publication-title: Nat Genet
  doi: 10.1038/s41588-022-01088-x
– volume: 112
  start-page: 1790
  issue: 12
  year: 2017
  ident: 3416_CR4
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2017.360
– volume: 15
  start-page: R46
  issue: 3
  year: 2014
  ident: 3416_CR25
  publication-title: Genome Biol
  doi: 10.1186/gb-2014-15-3-r46
– volume: 86
  start-page: 943
  issue: Pt 2
  year: 2022
  ident: 3416_CR17
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2021.10.004
– volume: 12
  start-page: 1054808
  year: 2022
  ident: 3416_CR32
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2022.1054808
– ident: 3416_CR42
  doi: 10.1183/13993003.02881-2020
SSID ssj0017837
Score 2.4634664
Snippet More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both...
Background More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and...
The bacteria (including Prevotella sp900557255, Alistipes putredinis, Megamonas funiformis, etc.) and viruses (including Lilyvirus, Felixounavirus, and...
The bacteria (including Prevotella sp900557255 , Alistipes putredinis , Megamonas funiformis , etc. ) and viruses (including Lilyvirus , Felixounavirus , and...
Abstract Background More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 264
SubjectTerms Adenoma - microbiology
Adenoma - virology
Advanced adenomas
Aged
Algorithms
Bacteria
Bacteria - classification
Bacteria - genetics
Bacteria - isolation & purification
Biological diversity
Biomarkers
Cancer
Care and treatment
Colonoscopy
Colorectal cancer
Colorectal Neoplasms - microbiology
Colorectal Neoplasms - virology
Comparative analysis
Composition
Data mining
Diagnosis
Enteroviruses
Escherichia coli
Feces
Feces - microbiology
Feces - virology
Female
Gastrointestinal Microbiome - genetics
Genomes
Gut bacteria
High-Throughput Nucleotide Sequencing
Homeostasis
Hospitals
Humans
Inflammatory bowel disease
Informed consent
Irritable bowel syndrome
Lipids
Machine Learning
Male
Metagenomic sequencing
Methods
Microbiota (Symbiotic organisms)
Microorganisms
Middle Aged
Patient compliance
Patients
Prediction model
Prediction models
Prevention
Rectal polyps
Risk factors
Software
Tumors
Typing
Veganism
Viruses
Viruses - classification
Viruses - genetics
Viruses - isolation & purification
Viruses - pathogenicity
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEB9kQfAirp_VVaoIHiRsP_J5XMV19eBBXdhbSNJEBW3FvnfY_eudSdvHK4JevJVkAulvJpnf0OkMwHPVJY1-SLDURcmQgXPmTGUYcWvTeokkP2dbfJBn5_z9hbjYa_VFOWFTeeAJuONkuEIfIn2nI_cdmlPFg3NKG02-Pwc-6POWYGr-fqAw7lp-kdHyeMRbWFKyLWcVXtuSXa3cUK7W_-edvOeU1gmTex7o9BbcnKljeTJt-RCuxf42XJ-aSV7eAfZ2uyl_UH6dj2M59CVSu5Iyx8shlcunfnyIPaUE3YXz0zefX5-xuRkCC8LoDVPOeN2F4FNETlNRnbkkVMJoISFpwXETVPKNCDrFgALOmNhEkSqdahzv2ntw0A99fACl9LUT0aXUGgSjFk5w17St06JrRMtVAfWCjQ1zpXBqWPHd5ohBSzvhaRFPm_G0VwW83K35OdXJ-Kv0K4J8J0k1rvMAat7Omrf_0nwBz0hhlqpY9JQm88Vtx9G--_TRnqDfpS7KvCngxSyUBnyH4Oa_DhAJKny1kjxaSeIxC-vpxS7sfMxH26LlNUgwuS7g6W6aVlLqWh-HLclgBNcopXDD9ycz2r036gkjWCkL0CsDWwGznum_fc1FwJEnC2SX9cP_AeUjuNHkw6FYrY_gYPNrGx8j2dr4J_lc_QbWrSGN
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9YwDI5gCInLxDdlAxWExAFF60c-T2ggxuDAAZj03qI0TbZJo93W9z2wXz87TcsqpN2qxJVax7Efp09tQt7JNiiIQ5yG1gsKCJxRqwtNEVvruhEA8iPb4oc4PGLfV3yVDtyGRKucfGJ01G3v8Ix8r4bAVkEsZ-rj-QXFrlH4dTW10LhL7mHpMrRquZoTrlJC9jX9KKPE3gC-WCDlltECnLegV4tgFGv2_--Zb4SmJW3yRhw6eEi2E4DM98cVf0Tu-O4xuT-2lPz7hNCvm3X-B1l2jR_yvssB4OXIH8_7kE8f_OHCd0gMekqODr78_nxIU0sE6rhWayqtblTrXBM8IJsCq80FLgPkDAGgC4xrJ0NTcaeCdyBgtfaV56FQoYTxtn5Gtrq-8y9ILprScm9DqDUoo-SWM1vVtVW8rXjNZEbKSTfGpXrh2LbizMS8QQkz6tOAPk3Up7nKyIf5nvOxWsat0p9Q5bMkVrqOA_3lsUkbxwTNJGAI0bTKs6YFd1IwZ61UWiH2KzPyFhfMYC2LDskyx3YzDObbr59mH6Iv9lJmVUbeJ6HQwzs4m_49AE1g-auF5O5CEjabW05PdmHSZh_MP9PMyJt5Gu9EAlvn-w3KQB5XSSnhgZ-PZjS_N6wT5LFCZEQtDGyhmOVMd3oSS4EDWuaAMcuXtz_XDnlQRbOXtFS7ZGt9ufGvAEytm9dxx1wDMb8Z-Q
  priority: 102
  providerName: ProQuest
Title Gut microbes on the risk of advanced adenomas
URI https://www.ncbi.nlm.nih.gov/pubmed/39026166
https://www.proquest.com/docview/3091292948
https://www.proquest.com/docview/3082627771
https://pubmed.ncbi.nlm.nih.gov/PMC11256391
https://doaj.org/article/f9476616bd8e4bd79304caa789845611
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFD70guCLeG-0LlEEH2Q0l7k-iHSltQoWWV1YfBkmyUwVaqKbXbD99Z6ZJGuDpS_LMnOyJCfn8p3sl3MAnovKScxDjLjKcoIInBKjEkU8tlZ5wRHkB7bFCT-e048LttiCYdxRr8D2ytLOz5OaL89e_fl9_hYd_k1weMlftxhjuafSUpJgUObkYht2MTMJP9HgE_33r4KQoYdmigGZYGpLhpdorvyNUaIK_fz_j9qX0taYUnkpRx3dhls9uIwPOmu4A1u2vgs3unGT5_eAvF-v4p-egVfYNm7qGMFf7LnlcePigQyAX2ztSUP3YX50-PXdMenHJZCSKbkiwqhCVmVZOIuoJ_Gd6BwTDusJh7AG11UpXJGxUjpbooBRymaWuUS6FNer_AHs1E1t9yDmRWqYNc7lCpWRMsOoyfLcSFZlLKcignTQjS77XuJ-pMWZDjWF5LrTp0Z96qBPfRHBy80xv7pOGtdKT73KN5K-C3ZYaJanuncq7RQViC94UUlLiwpDTUJLY4RU0uPCNIJn_oZp3-ei9kSaU7NuW_3hy0wfYGb2c5ZpFsGLXsg1eA2l6d9LQE341lgjyf2RJDpiOd4e7EIPdqxzxGMZQlAqI3i62fZHenJbbZu1l8EaLxNC4Ak_7Mxoc914n7DG5TwCOTKwkWLGO_WP76FNOCJphvgzfXT9aT-Gm6nCcBmeLO3Dzmq5tk8QaK2KCWyLhZjA7vTw5PNsEh5XTIJH4eds-u0v-gIjdg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4k2gQEAgDshq4sSvA0LlUXZp6QFaaW-u49ilUklKsyvU_ih-IzN5LI2QeustsidRMp7x983ueIaQl7IMCnCI01B6QYGB59TqRFPk1jorBJD8NttiR0z28i8zPlshf4azMJhWOeyJ7UZd1g5_I1_PANgYYHmu3h3_otg1Cv9dHVpodGax5U9_Q8jWvJ1-hPV9xdjmp90PE9p3FaCOazWn0upClc4VwQM5SLBgW-AyAO0OgP4wrp0MBeNOBe9AwGrtmechUSGF8TKD514hVwF4Ewz25GwZ4KUSor3hYI4S6w3s_QJTfHOaAFgIejYCv7ZHwP9IcA4Kx2ma53Bv8xa52RPWeKOzsNtkxVd3yLWuheXpXUI_L-bxT8zqK3wT11UMhDLGfPW4DvGQYAAXvsJEpHtk71KUdZ-sVnXlH5JYFKnl3oaQaVBGyi3PLcsyq3jJeJbLiKSDbozr65Njm4wj08YpSphOnwb0aVp9mrOIvFnec9xV57hQ-j2qfCmJlbXbgfrkwPSOaoLOJXAWUZTK50UJ21eSO2ul0gq5ZhqRF7hgBmtnVJicc2AXTWOm37-ZDUB77N2cs4i87oVCDd_gbH_WATSB5bZGkmsjSXBuN54e7ML0m0tj_rlCRJ4vp_FOTJirfL1AGYgbmZQSXvhBZ0bL74Z1grhZiIiokYGNFDOeqQ5_tKXHgZ1z4LTpo4vf6xm5Ptn9um22pztbj8kN1rqApKlaI6vzk4V_AkRuXjxtvScm-5ftrn8BLLRY1A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gut+microbes+on+the+risk+of+advanced+adenomas&rft.jtitle=BMC+microbiology&rft.au=Jing%2C+Zhuang&rft.au=Zheng%2C+Wu&rft.au=Jianwen%2C+Song&rft.au=Hong%2C+Shen&rft.date=2024-07-18&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2180&rft.eissn=1471-2180&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12866-024-03416-z&rft.externalDocID=A801883342
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2180&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2180&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2180&client=summon